Clinical trial: Trexima versus butalbital meds for migraines
(National Institutes of Health) UPDATED 2008-10-09
This study will compare Trexima to to a butalbital-containing combination medication, acetaminophen, caffeine, and the butalbital med Fioricet in people who suffer from migraines. This national study is currently recruiting adults ages 18 years to 65 years old who have migraines and already take a a butalbital-containing medication.
Read full story >
See all Migraine News